To get a sense of who is truly in control of Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), it is important to understand the ownership structure of the business. With 58% stake, individual investors ...
In two separate filings with the U.S. Securities and Exchange Commission, Armistice Capital, led by Steven Boyd, disclosed massively cutting its activist stake in Spectrum Pharmaceuticals Inc. (NASDAQ ...
Armistice Capital is a value-oriented and event-driven fund that was launched in 2012 by Steven Boyd. During his first year, Mr. Boyd managed to return an impressive 48%. He has gained experience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results